Structure via PubChem · Public domain (PubChem)
dapsone
Sign in to saveAlso known as 4,4'-Diaminodiphenylsulfone, DDS, 4,4'-Sulfonyldianilin, 4,4'-sulfonyldianiline, DADPS, P,P-Sulphonylbisbenzamine, Bis(P-aminophenyl) sulfone, P,P'-diaminodiphenyl sulfone
Key facts
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 460773489
- Drug.IUPAC_name
- 4-[(4-aminobenzene)sulfonyl]aniline
- Drug.image
- Dapsone.svg
- Drug.image_class
- skin-invert-image
- Drug.image2
- Dapsone3d.png
- Drug.image_class2
- bg-transparent
- Drug.tradename
- Aczone, others
- Drug.MedlinePlus
- a682128
- Drug.DailyMedID
- Dapsone
- Drug.pregnancy_US
- C
- Drug.routes_of_administration
- By mouth, topical
- Drug.legal_AU
- S4
- Drug.legal_US
- Rx-only
- Drug.legal_status
- Rx-only
- Drug.bioavailability
- 70 to 80%
- Drug.protein_bound
- 70 to 90%
- Drug.metabolism
- Liver (mostly CYP2E1-mediated)
via Wikipedia infobox
Chemical data
- Formula
- C12H12N2O2S
- Molecular weight
- 248.3 g/mol
- IUPAC name
- 4-(4-aminophenyl)sulfonylaniline
- SMILES
- C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
- InChIKey
- MQJKPEGWNLWLTK-UHFFFAOYSA-N
- XLogP
- 1
- Polar surface area
- 94.6 Ų
- H-bond donors
- 2
- H-bond acceptors
- 4
- Formal charge
- 0
via PubChem
Research
7,492 papers- Dapsone Use in Dermatology.American journal of clinical dermatology · 2024
- Dapsone.Dermatology online journal · 2002
- Dapsone for acne: Still in use after half a century!Journal of cosmetic dermatology · 2021
- Dapsone-associated fixed drug eruption.Expert review of clinical pharmacology · 2017
- Dapsone-induced methemoglobinemia.The Annals of pharmacotherapy · 1998
via PubMed
Wikidata facts
- Mass
- 248.061949
Show 6 more facts
- melting point
- 177
- chemical formula
- C₁₂H₁₂N₂O₂S
- World Health Organisation international non-proprietary name
- dapsone
- canonical SMILES
- C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
- defined daily dose
- 50
- Commons category
- Dapsone
Sources (7)
via Wikidata · CC0
~12 min read
Article
20 sectionsContents
- Medical uses
- Infections
- Autoimmune disease
- Other
- Contraindications and precautions
- Adverse effects
- Blood
- Liver
- Skin
- Dapsone hypersensitivity syndrome
- Other adverse effects
- Mechanism of action
- History
- Discovery
- Proposed use in antimalarial drugs
- Dapsone gel
- Other uses
- See also
- References
- External links
Dapsone, also known as '''4,4'-sulfonyldianiline (SDA) or diaminodiphenyl sulfone (DDS'''), is an antibiotic commonly used in combination with rifampicin and clofazimine for the treatment of leprosy. It is a second-line medication for the treatment and prevention of pneumocystis pneumonia and for the prevention of toxoplasmosis in those who have poor immune function. Additionally, it has been used for acne, dermatitis herpetiformis, and various other skin conditions. Dapsone is available both topically and by mouth.
Severe side effects may include a decrease in blood cells, red blood cell breakdown especially in those with glucose-6-phosphate dehydrogenase deficiency (G-6-PD), or hypersensitivity. Common side effects include nausea and loss of appetite. Other side effects include liver inflammation, methemoglobinemia, and a number of types of skin rashes. While the safety of use during pregnancy is not entirely clear some physicians recommend that it be continued in those with leprosy. It is of the sulfone class.